Ashvattha Therapeutics, Inc. — Form D
Ashvattha Therapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-31. The offering totals $6.4M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-31
- Form: D
- Accession: 0001144204-19-029203
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.4M
- Amount sold: $250K
- Remaining: $6.2M
- Investors: 1
- Date of first sale: 2019-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-340849
Issuer
- Name: Ashvattha Therapeutics, Inc.
- CIK: 0001668528
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2015
- Address: 1235 RADIO ROAD, SUITE 200, REDWOOD CITY, CA, 94065
- Phone: (650) 868-5853
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Sujatha Kannan | Executive Officer | Highland, MD |
| JEFFREY CLELAND | Director | BALTIMORE, MD |
| JEFFREY CLELAND | Executive Officer | BALTIMORE, MD |
| Jay Zaveri | Director | Campbell, CA |
| Yuhang Zhao | Director | Redwood City, CA |
| George Montgomery | Director | Redwood City, CA |
| Kannan Rangaramanujam | Director | Highland, MD |
| Kannan Rangaramanujam | Executive Officer | Highland, MD |
| Sujatha Kannan | Director | Highland, MD |
| Barbara Slusher | Director | Redwood City, CA |
| Justin Hanes | Executive Officer | Redwood City, CA |
Other filings by this issuer (6)
More